As medical devices incorporate connectivity, they provide greater opportunities for convenience, service, and information for consumers and companies, but also are increasingly vulnerable to cyber threats. In this environment, Attivo Networks and Becton, Dickinson and Co. (BD) have validated a deception solution for medical technology cybersecurity threats through a partnership bringing Attivo’s Botsink solution to a select number of BD devices. The two firms collaborated through BD’s Product Security Partnership Program and created “mirror-match decoy authenticity” software for some of BD’s devices, a method designed to redirect an attack from reaching important information or networks.
Attivo, based in Fremont, Calif., explained the solution as a way to misdirect an attacker toward a fake digital environment, which would mirror the actual one but not allow access to sensitive information or the ability to upload malicious software. The hacker or cyberattacker also could be tracked during their attempts to access networks. As part of the collaboration, which first began with determining compatibility between Attivo’s technology and Franklin Lakes, N.J.-based BD devices, Botsink will add a layer of protection with BD’s Alaris infusion systems.